CUREDUCHENNE VENTURES
CUREDUCHENNE VENTURES
Status:
Active
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | CureDuchenne Ventures investment in Series A - Code Biotherapeutics | 75 M USD |
| 2021-12-22 | Gennao Bio | CureDuchenne Ventures investment in Series A - Gennao Bio | 1000 K USD |
| 2021-08-05 | Pepgen | CureDuchenne Ventures investment in Venture Round - Pepgen | 112.5 M USD |
| 2021-04-20 | Code Biotherapeutics | CureDuchenne Ventures investment in Seed Round - Code Biotherapeutics | 10 M USD |
| 2021-03-31 | Entrada Therapeutics | CureDuchenne Ventures investment in Series B - Entrada Therapeutics | 116 M USD |
| 2020-12-09 | Pepgen | CureDuchenne Ventures investment in Series A - Pepgen | 45 M USD |
| 2020-12-08 | Edgewise Therapeutics | CureDuchenne Ventures investment in Series C - Edgewise Therapeutics | 95 M USD |
| 2020-11-10 | Mesentech | CureDuchenne Ventures investment in Venture Round - Mesentech | N/A |
| 2020-04-23 | Myosana Therapeutics | CureDuchenne Ventures investment in Seed Round - Myosana Therapeutics | 1000 K USD |
| 2019-11-13 | Avidity Biosciences | CureDuchenne Ventures investment in Series C - Avidity Biosciences | 100 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-13 | Cureduchenne Strengthens Research and Investment Team With Addition of Vice President of Research and Partner of CureDuchenne Ventures |
More informations about "CureDuchenne Ventures"
CureDuchenne
The CureDuchenne one-to-one program provides meetings with our scientists, physical therapists, parents, fundraising team and family support resource coordinators. Email us at [email protected] to set up a time that …See details»
CureDuchenne Ventures – Our Impact
CureDuchenne Impact: CureDuchenne has invested more than $26M in research through grants and investments. Of that $26M, $22.2M in biotech investments has led to follow-on funding of more than $3B from other investors and …See details»
Home Page - CureDuchenne
CureDuchenne does not provide medical advice nor is CureDuchenne a medical provider. The intent of this shared content is to serve as a point of reference for informational purposes. Please refer to your health care provider(s) for your …See details»
CureDuchenne Ventures Launched to Accelerate Drug Discovery …
Sep 26, 2013 CureDuchenne announced today the launch of CureDuchenne Ventures, a new initiative to identify and develop a robust pipeline of therapies to treat Duchenne, the most …See details»
CureDuchenne Ventures - Crunchbase Investor Profile …
CureDuchenne Ventures is a private equity firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Early Stage Venture Investors with Investments in Oxfordshire . 530 Number of Organizations • $62.3B Total …See details»
CureDuchenne - The Org
CureDuchenne is the global leader in Duchenne research, patient care and innovation. We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the …See details»
CureDuchenne – Muscular Dystrophy News
CureDuchenne is a global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne muscular dystrophy. Skip to content. Toggle …See details»
Debra Miller - Founder And CEO at CureDuchenne - The Org
Debra Miller is the CEO and founder of CureDuchenne. Debra founded the organization in 2003 and has made significant contributions to accelerating drug development towards a cure for …See details»
CureDuchenne Ventures LLC to Provide $1 Million to Capricor ...
Jan 12, 2015 CureDuchenne Ventures LLC was formed by CureDuchenne, a national nonprofit that has a successful track record of supporting research and raising awareness of the …See details»
Cure Duchenne Ventures LLC To Provide $1 Million to Capricor ...
Jan 13, 2015 NEWPORT BEACH, Calif.--CureDuchenne Ventures LLC, a company that funds research to find a cure for Duchenne muscular dystrophy that was formed by the nonprofit …See details»
CureDuchenne 2025 Company Profile: Valuation, Funding
CureDuchenne General Information Description. Provider of patient care services intended to improve the lives of those affected by Duchenne muscular dystrophy. The company does …See details»
CureDuchenne Ventures investment portfolio - PitchBook
CureDuchenne Ventures's latest investment was on 15-Oct-2024 in DNA Nanobots, a company within the Biotechnology industry. Data Transparency. Meet our data hygiene team. Discover …See details»
CureDuchenne Ventures prioritizes bone health in Duchenne …
Nov 10, 2020 CureDuchenne Ventures is happy to announce an investment in Mesentech, a company based in Vancouver, Canada, that has a novel therapeutic approach for improving …See details»
CUREDUCHENNE ADDS VICE PRESIDENT OF RESEARCH AND …
Newport Beach, Calif. – May 13, 2022 – CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy (DMD), today announced the …See details»
CureDuchenne Cares Workshop - Woodbridge, NJ - Facebook
Event in Woodbridge, NJ by CureDuchenne on Saturday, October 17 20156 posts in the discussion.See details»
Venture Capital | Werth Family Investment Associates | Woodbridge
Werth Family Investment Associates is a family office focsed on making venture investments within the healthcare industry. Musan Duric, Investment Portfolio Manager Peter J. Werth, …See details»
58 Top Healthcare Companies in New Jersey · April 2025 | F6S
Apr 1, 2025 Healthcare companies snapshot. We're tracking Amicus Therapeutics, Enhatch and more Healthcare companies in New Jersey from the F6S community. Healthcare forms part of …See details»
Reports and Financials - CureDuchenne
CureDuchenne does not provide medical advice nor is CureDuchenne a medical provider. The intent of this shared content is to serve as a point of reference for informational purposes. …See details»
Woodbridge Ventures 2025 Company Profile: Valuation, Investors ...
The current valuation of Woodbridge Ventures is . What is Woodbridge Ventures’s current revenue? The current revenue for Woodbridge Ventures is . How much funding has …See details»
Dyne Therapeutics Announces Equity Investment from …
WALTHAM, Mass., March 31, 2020 – Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced an equity …See details»